Literature DB >> 19449338

Subcellular localization of antizyme inhibitor 2 in mammalian cells: Influence of intrinsic sequences and interaction with antizymes.

Andrés J López-Contreras1, Berta L Sánchez-Laorden, Bruno Ramos-Molina, María E de la Morena, Asunción Cremades, Rafael Peñafiel.   

Abstract

Ornithine decarboxylase (ODC) and the antizyme inhibitors (AZIN1 and AZIN2), regulatory proteins of polyamine levels, are antizyme-binding proteins. Although it is widely recognized that ODC is mainly a cytosolic enzyme, less is known about the subcellular distribution of AZIN1 and AZIN2. We found that these proteins, which share a high degree of homology in their amino acid sequences, presented differences in their subcellular location in transfected mammalian cells. Whereas ODC was mainly present in the cytosol, and AZIN1 was found predominantly in the nucleus, interestingly, AZIN2 was located in the ER-Golgi intermediate compartment (ERGIC) and in the cis-Golgi network, apparently not related to any known cell-sorting sequence. Our results rather suggest that the N-terminal region may be responsible for this particular location, since its deletion abrogated the incorporation of the mutated AZIN2 to the ERGIC complex and, on the other hand, the substitution of this sequence for the corresponding sequence in ODC, translocated ODC from cytosol to the ERGIC compartment. Furthermore, the coexpression of AZIN2 with any members of the antizyme family induced a shift of AZIN2 from the ERGIC to the cytosol. These findings underline the complexity of the AZs/AZINs regulatory system, supporting early evidence that relates these proteins with additional functions other than regulating polyamine homeostasis. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19449338     DOI: 10.1002/jcb.22168

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  Recurrent emergence of catalytically inactive ornithine decarboxylase homologous forms that likely have regulatory function.

Authors:  Ivaylo P Ivanov; Andrew E Firth; John F Atkins
Journal:  J Mol Evol       Date:  2010-03-09       Impact factor: 2.395

2.  Novel interaction of ornithine decarboxylase with sepiapterin reductase regulates neuroblastoma cell proliferation.

Authors:  Ingo Lange; Dirk Geerts; David J Feith; Gabor Mocz; Jan Koster; André S Bachmann
Journal:  J Mol Biol       Date:  2013-10-01       Impact factor: 5.469

3.  New insights of polyamine metabolism in testicular physiology: A role of ornithine decarboxylase antizyme inhibitor 2 (AZIN2) in the modulation of testosterone levels and sperm motility.

Authors:  Ana Lambertos; Bruno Ramos-Molina; Andrés J López-Contreras; Asunción Cremades; Rafael Peñafiel
Journal:  PLoS One       Date:  2018-12-19       Impact factor: 3.240

4.  A novel mechanism for A-to-I RNA-edited AZIN1 in promoting tumor angiogenesis in colorectal cancer.

Authors:  Yan Wei; Haowan Zhang; Qiaohui Feng; Shumin Wang; Youcheng Shao; Jie Wu; Ge Jin; Weiwei Lin; Xinxin Peng; Xiaoyan Xu
Journal:  Cell Death Dis       Date:  2022-04-02       Impact factor: 8.469

5.  Antizyme inhibitor 2 hypomorphic mice. New patterns of expression in pancreas and adrenal glands suggest a role in secretory processes.

Authors:  Carlos López-Garcia; Bruno Ramos-Molina; Ana Lambertos; Andrés J López-Contreras; Asunción Cremades; Rafael Peñafiel
Journal:  PLoS One       Date:  2013-07-12       Impact factor: 3.240

6.  Structural and degradative aspects of ornithine decarboxylase antizyme inhibitor 2.

Authors:  Bruno Ramos-Molina; Ana Lambertos; Andrés J Lopez-Contreras; Joanna M Kasprzak; Anna Czerwoniec; Janusz M Bujnicki; Asunción Cremades; Rafael Peñafiel
Journal:  FEBS Open Bio       Date:  2014-06-02       Impact factor: 2.693

7.  Polyamine biosynthesis in Xenopus laevis: the xlAZIN2/xlODC2 gene encodes a lysine/ornithine decarboxylase.

Authors:  Ana Lambertos; Rafael Peñafiel
Journal:  PLoS One       Date:  2019-09-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.